Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pingfu Fu

Showing results (171-180 of 268) with videos related to

Pageof 27
Sort By:
Journal of Medical Imaging (Bellingham, Wash.)|July 16, 2021
Computational pathology reveals unique spatial patterns of immune response in H&E images from COVID-19 autopsies: preliminary findingsGermán Corredor, Paula Toro, Kaustav Bera, et al.
Transplantation|November 30, 2005
Recipient-specific tolerance after HLA-mismatched umbilical cord blood stem cell transplantationThomas O Kleen, Suzanne Kadereit, Laura R Fanning, et al.
Bioconjugate Chemistry|March 8, 2021
Peptide Derivatives of Retinylamine Prevent Retinal Degeneration with Minimal Side Effects on Vision in MiceGuanping Yu, Song-Qi Gao, Zhiqian Dong, et al.
Cancer Research|July 3, 2008
15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancerGuosheng Huang, Rosana Eisenberg, Min Yan, et al.
JAMA Dermatology|February 16, 2017
Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical TrialJoselin D Tacastacas, Derek V Chan, Sean Carlson, et al.
Journal for Immunotherapy of Cancer|March 8, 2022
Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumabKhalid Jazieh, Mohammadhadi Khorrami, Anas Saad, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
High UDG and BRCA1 expression is associated with adverse outcome in patients with pemetrexed treated non-small cell lung CancerNooshin Hashemi Sadraei, Yan Feng, Lingling Du, et al.
Lasers in Surgery and Medicine|January 20, 2011
Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trialElma D Baron, Christi L Malbasa, Diana Santo-Domingo, et al.
Communications Medicine|January 3, 2024
Computational pathology identifies immune-mediated collagen disruption to predict clinical outcomes in gynecologic malignanciesArpit Aggarwal, Sirvan Khalighi, Deepak Babu, et al.
Oncotarget|November 8, 2017
Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignanciesPaolo F Caimi, Brenda W Cooper, Basem M William, et al.
Pageof 27

Showing results (171-180 of 268) with videos related to

Sort By:
Pageof 27
Journal of Medical Imaging (Bellingham, Wash.)|July 16, 2021
Computational pathology reveals unique spatial patterns of immune response in H&E images from COVID-19 autopsies: preliminary findingsGermán Corredor, Paula Toro, Kaustav Bera, et al.
Transplantation|November 30, 2005
Recipient-specific tolerance after HLA-mismatched umbilical cord blood stem cell transplantationThomas O Kleen, Suzanne Kadereit, Laura R Fanning, et al.
Bioconjugate Chemistry|March 8, 2021
Peptide Derivatives of Retinylamine Prevent Retinal Degeneration with Minimal Side Effects on Vision in MiceGuanping Yu, Song-Qi Gao, Zhiqian Dong, et al.
Cancer Research|July 3, 2008
15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancerGuosheng Huang, Rosana Eisenberg, Min Yan, et al.
JAMA Dermatology|February 16, 2017
Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical TrialJoselin D Tacastacas, Derek V Chan, Sean Carlson, et al.
Journal for Immunotherapy of Cancer|March 8, 2022
Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumabKhalid Jazieh, Mohammadhadi Khorrami, Anas Saad, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
High UDG and BRCA1 expression is associated with adverse outcome in patients with pemetrexed treated non-small cell lung CancerNooshin Hashemi Sadraei, Yan Feng, Lingling Du, et al.
Lasers in Surgery and Medicine|January 20, 2011
Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trialElma D Baron, Christi L Malbasa, Diana Santo-Domingo, et al.
Communications Medicine|January 3, 2024
Computational pathology identifies immune-mediated collagen disruption to predict clinical outcomes in gynecologic malignanciesArpit Aggarwal, Sirvan Khalighi, Deepak Babu, et al.
Oncotarget|November 8, 2017
Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignanciesPaolo F Caimi, Brenda W Cooper, Basem M William, et al.
Pageof 27